Two Sigma Investments, LP Meridian Bioscience Inc Transaction History

Two Sigma Investments, LP

$42.3 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$23.75 - $31.69 $802,678 - $1.07 Million	33,797 Added 86.63%	72,809 $2.22 Million
Q1 2022 May 16, 2022	BUY	$19.97 - $26.94 $779,069 - $1.05 Million	39,012 New	39,012 $1.01 Million
Q4 2021 Feb 14, 2022	SELL	$17.46 - $21.61 $804,417 - $995,615	-46,072 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$17.35 - $22.5 $799,349 - $1.04 Million	46,072 New	46,072 $886,000
Q2 2020 Aug 14, 2020	SELL	$7.84 - $23.29 $433,450 - $1.29 Million	-55,287 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$5.57 - $11.5 $85,510 - $176,548	-15,352 Reduced 21.73%	55,287 $464,000
Q4 2019 Feb 14, 2020	BUY	$7.9 - $10.14 $558,048 - $716,279	70,639 New	70,639 $690,000
Q3 2019 Nov 14, 2019	SELL	$9.17 - $12.01 $92,231 - $120,796	-10,058 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$10.88 - $17.6 $109,431 - $177,020	10,058 New	10,058 $119,000
Q1 2019 May 15, 2019	SELL	$15.51 - $17.61 $1.7 Million - $1.93 Million	-109,339 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$14.52 - $19.72 $1.04 Million - $1.41 Million	71,318 Added 187.58%	109,339 $1.9 Million
Q3 2018 Nov 14, 2018	SELL	$14.85 - $16.35 $1.49 Million - $1.64 Million	-100,458 Reduced 72.54%	38,021 $567,000
Q2 2018 Aug 14, 2018	BUY	$13.8 - $16.8 $1.01 Million - $1.23 Million	73,060 Added 111.68%	138,479 $2.2 Million
Q1 2018 May 15, 2018	SELL	$13.8 - $16.2 $1.61 Million - $1.89 Million	-116,525 Reduced 64.04%	65,419 $929,000
Q4 2017 Feb 14, 2018	BUY	$13.55 - $15.8 $523,707 - $610,670	38,650 Added 26.97%	181,944 $2.55 Million
Q3 2017 Nov 14, 2017	BUY	$13.45 - $14.35 $1.93 Million - $2.06 Million	143,294	143,294 $2.05 Million

Others Institutions Holding VIVO

# of Institutions

Shares Held

113K

Call Options Held

Put Options Held

View Full List

About MERIDIAN BIOSCIENCE INC

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

More about VIVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account